<DOC>
	<DOCNO>NCT00245830</DOCNO>
	<brief_summary>The long-term goal proposal develop clinical protocol donor precondition improve liver graft function ameliorate complication poor graft function liver transplantation . Achievement objective would improve liver recipient outcome , increase utilization liver alleviate current critical shortage liver transplantation . More stringent liver donor selection intend decrease complication poor graft function conflict directly effort maximize use donor liver . Ischemic preconditioning ( IPC ) liver attenuate hepatic ischemia reperfusion injury ( IRI ) animal . Preliminary data show hepatic IPC effectively decrease IRI follow hepatic resection human . The specific aim project : AIM 1 : To test hypothesis 10 minute hepatic ischemic preconditioning deceased donor would improve liver graft function decrease injury early post transplant period . AIM 2 : To test hypothesis ischemic preconditioning decease donor liver would decrease systemic inflammatory response liver recipient early post transplant period . AIM 3 : To examine whether ischemic preconditioning decease donor liver decrease early post transplant pulmonary edema acute rejection shorten hospital stay .</brief_summary>
	<brief_title>Ischemic Preconditioning Liver Cadaver Donors</brief_title>
	<detailed_description>Specific Aims 1 . To test hypothesis 10 minute hepatic ischemic preconditioning deceased donor would improve liver graft function decrease injury early post transplant period . To accomplish aim , compare International Normalized Ratios prothrombin time ( INR/PT ) serum aspartate ( AST ) alanine aminotransferase ( ALT ) total bilirubin ( TB ) level immediately post transplant day 1 , 3 , 7 , 14 30 injury score reperfusion liver biopsy recipients liver IPC No IPC donor . 2 . To test hypothesis ischemic preconditioning decease donor liver would decrease systemic inflammatory response liver recipient early post transplant period . To accomplish aim , compare plasma level cytokine tumor necrosis factor-alpha ( TNF-alpha ) , interleukins-6 , 8 10 ( IL-6 , 8 10 ) soluble L-selectin , expression level adhesion molecule ( CD11beta/CD18 L-selectin ) oxidative burst neutrophil , platelet P-selectin platelet-neutrophil complex ( PNC ) peripheral blood 3 , 12 , 24 48 hour follow reperfusion recipient liver IPC No IPC donor . 3 . To examine whether ischemic preconditioning decease donor liver decrease early post transplant pulmonary edema acute rejection shorten hospital stay . To accomplish aim , compare interstitial alveolar edema chest radiograph do transplant post operative day 1 , 2 3 ; biopsy confirm acute rejection within 30 day post transplant , number day discharge transplantation recipient liver IPC No IPC donor . Research Design A prospective , randomize , single mask ( liver recipient ) study conduct one liver transplant center period two year . Deceased liver donor randomize equal proportion one two organ recovery procedure : 1 ) . IPC 2 ) . No IPC . Allocation stratify age &lt; 50 age &gt; = 50 facilitate examination effect age IPC . As trial enroll donor two-year period , treatment assignment balance block length 12 , 16 20 , length select random , control time vary factor . Recovered liver transplant recipient &gt; 18 year age . All aspect donor management , organ recovery preservation , recipient selection , graft implantation post transplant management include immunosuppression accord standard practice . II . Research Methods 1 . Liver Recovery IPC : Donors position supine , mechanically ventilate administer 100 % oxygen muscle relaxant . The abdomen chest open midline . Briefly , round falciform ligament divide gallbladder incise irrigate . The gastroduodenal artery ligate junction splenic superior mesenteric vein , pancreas procure , inferior mesenteric vein prepared canulation . The supraceliac aorta expose diaphragm . The infrarenal abdominal aorta isolated canulation . No mobilization kidney perform organ perfusion . Thoracic organs mobilize either simultaneously mobilization abdominal organ . Five hundred units/kg heparin give intravenously ascend thoracic infrarenal abdominal aorta canulate . Another canula insert either splenic vein inferior mesenteric vein . The supraceliac abdominal aorta clamp inferior vena cava vent pericardium . UW solution ( 40C ) infuse abdominal aorta portal vein ( 2 liter ) . The abdominal cavity pack ice slush . Following completion organ perfusion heart , lung , liver pancreas kidney remove sequence . Livers place plastic bag contain liter UW solution ( 40C ) pack ice time transplantation . Ischemic preconditioning perform soon open abdomen clamp hepatic hilum vascular clamp five minute , repeat five minute reperfusion . During IPC peritoneal cavity inspect bleeding , congestion edema pancreas small intestine . 2 . Graft Implantation : Recipient hepatectomy do standard manner caval preservation without utilization venovenous bypass . The liver graft implant piggyback manner88 . The allograft reperfused completion suprahepatic caval portal vein anastomosis . The graft flush approximately 300 ml recipient blood , vent via donor 's infrahepatic vena cava , structure ligate . Arterial bile duct anastomosis complete graft reperfusion . 3 . Liver Biopsy Reperfusion Injury : A wedge needle biopsy right lobe perform immediately upon open donor 's abdomen IPC . Another wedge needle biopsy do 90 min recipient reperfusion . Liver biopsy transplantation perform clinically indicate . Formalin fix specimen embed paraffin , section five micron thin stain hematoxylin eosin . The amount fat donor biopsy grade semi-quantitatively follows89 ; No fat = grade 0 , 1-15 % = grade I , 16-30 % = grade II , 31-45 % = grade III , &gt; 45 % = grade IV . Reperfusion injury grade ( 0-10 increase severity ) examine 30 high power field ( 600x ) post perfusion biopsy . Apoptotic cell enumerate hepatocyte swell , zone 3 hemorrhage necrosis assign semi-quantitative score90 . The reperfusion score propose study expect range 0.5 5 base previous work36 . The pathologist mask regard group assignment biopsy . 4 . Immunosuppression Acute Rejection : All patient receive tacrolimus steroid immunosuppression . In patient hepatorenal syndrome tacrolimus use delay several day may use much low dose standard use . Pharmacological immunosuppression quantify determine mean dose steroid per day , mean weekly median tacrolimus level first five week proportion recipient group might receive agent mycophenolate IL-2 receptor antibody . Immunosuppresion cause recipient 's liver failure assess model end stage liver disease ( MELD ) score time transplantation . Following transplantation liver biopsy perform clinically indicate . Acute cellular rejection diagnose least two three follow criterion present : portal mononulclear infiltration , bile duct inflammation/damage subendothelial inflammation portal venule and/or terminal hepatic venule . Severity rejection grade base rejection activity index follow : 0-2 = rejection , 3 = borderline , 4-5 = mild , 6-7 = moderate 8-9 = severe91 . Mild rejection treat initially escalation prograf dose alone combination steroid . Steroid resistant rejection , upon confirmation biopsy treat muromonab ( OKT3 ) . 5 . Plasma TNF-alpha , IL-6 8 , soluble L-selectin : Plasma separate systemic venous blood take 3 , 12 , 24 , 48 hour reperfusion recipient liver without IPC sample store -700C . TNF-alpha , IL-6 IL-8 soluble L-selectin level quantitated commercially available enzyme-linked immunosorbent assay kit ( R &amp; D Systems , Minneapolis , MN ) duplicate . The assay perform accord manufacturer 's instruction . 6 . Neutrophil CD11beta/CD18 L-selectin , Platelet P-selectin Platelet-Neutrophil Complexes Oxidative burst Neutrophils peripheral blood : Systemic venous blood collect heparinized ( 10 U/ml ) syringe 3 , 12 , 24 48 hour reperfusion recipient liver without IPC . Fifty microL blood add saturate concentration fluorescein isothiocyante ( FITC ) , phycoerythrin ( PE ) conjugate monoclonal antibody ( Dako Corp , Carpenteria , CA ) CD 11beta/CD18 , CD 62 L ( L-selectin ) , CD 42 ( platelet von Willebrand factor receptor ) , CD 62P ( P-selectin ) . Following 10 min incubation room temperature , red cell lysed addition 200 microL FACSlyse ( Becton Dickinson , Franklin Lakes , NJ ) . After 10 min incubation 250 microL 0.2 % formaldehyde PBS add . Samples analyze FasCalibur flow cytometry ( Becton Dickinson , Fair Lakes , NJ ) . Fluorescence FITC measure 515 nm PE 580 nm . Neutrophils distinguish readily identifiable characteristic forward side-scatter plot . A minimum 5000 neutrophil event count . Events stain positive CD 11beta CD 42 consider PNC describe Peters et al72 . To minimize risk identify individual platelet neutrophils PNC flow rate adjust result &lt; 4500 events/sec . Results consider positive fluorescence intensity exceed 98 % isotype match control antibody . Results express median fluorescence intensity ( MFI ) . Oxidative burst measure utilization oxidation dihydrorhodamine florescent rhodamine neutrophil generate reactive oxygen specie describe Vowells et al92 . Briefly , 300 microL heparinized whole blood add 4 ml red cell lysis buffer ( 370C ) . After five minute incubation pellet resuspend HBSS contain 5 % fetal calf serum . 1.8 microL DHR DMSO add incubated room temperature 10 min follow flow cytometric analysis . Stimulation PMA ( 1microg/ml ) use positive control . 7 . Pulmonary Edema : Chest radiograph perform antero-posterior projection patient semi-erect position upon completion transplant postoperative day 1 , 2 3 . Pulmonary edema assess presence absence interstitial edema alveolar edema per accept criteria93 . The radiologist mask regard group assignment subject .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Cadaver</mesh_term>
	<criteria>Deceased donor liver allocate adult ( &gt; 18 year age ) recipients research site . 1 . Deceased donor liver allocate recipient center research site . 2 . Deceased donor liver allocate recipient &lt; 18 year age research site . 3 . Nonheart beat donor 4 . Deceased liver small intestine donor 5 . Live liver donor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Ischemia/reperfusion liver</keyword>
	<keyword>Ischemic Preconditioning</keyword>
	<keyword>Cadaver organ donor</keyword>
</DOC>